• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Remix Therapeutics Remix Therapeutics
  • Science
  • People
  • Join Us
  • News & Media
  • Contact
  • Privacy Policy
  • Terms of Use

News & Media

Press Release
Remix Therapeutics Appoints Matthew R. Patterson as Executive Chairman of its Board of Directors >
Press Release
Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing >
Media Contact

Lissette Steele

Verge Scientific

Communications

202.930.4762

lsteele@vergescientific.com

Media Contact

Lissette Steele

Verge Scientific

Communications

202.930.4762

lsteele@vergescientific.com

sidebar

sidebar-alt

Footer

One Kendall Square, Building 600, Cambridge, MA 02139

© Remix Therapeutics 2020. All Rights Reserved

  • Privacy Policy
  • Terms of Use